BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Up 24.4% in March

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 31,600 shares, a growth of 24.4% from the February 28th total of 25,400 shares. Based on an average daily trading volume, of 87,400 shares, the short-interest ratio is presently 0.4 days. Currently, 0.3% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, HC Wainwright upped their target price on BiomX from $2.00 to $21.00 and gave the company a “buy” rating in a research report on Tuesday.

BiomX Price Performance

NYSEAMERICAN PHGE traded down $0.06 on Tuesday, reaching $0.49. The stock had a trading volume of 154,152 shares, compared to its average volume of 92,832. The firm has a market cap of $8.96 million, a price-to-earnings ratio of -0.15 and a beta of 1.27. BiomX has a 1-year low of $0.48 and a 1-year high of $4.99.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).